US Stock MarketDetailed Quotes

DSGN Design Therapeutics

Watchlist
  • 4.570
  • -0.200-4.19%
Close May 10 16:00 ET
  • 4.520
  • -0.050-1.09%
Post 19:51 ET
258.18MMarket Cap-4394P/E (TTM)

About Design Therapeutics Company

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.

Company Profile

SymbolDSGN
Company NameDesign Therapeutics
Listing DateMar 26, 2021
Issue Price20.00
Founded2017
CEODr. Pratik Shah, PhD
MarketNASDAQ
Employees124
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address6005 Hidden Valley Road,Suite 110
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92011
Phone1-858-293-4900
Websitehttp://www.designtx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Pratik Shah, PhD
  • Chairperson of the Board, President, Chief Executive Officer and Principal Financial Officer
  • 6.32M
  • Dr. Sean Jeffries, PhD
  • Chief Operating Officer
  • 1.28M
  • Dr. Jae B. Kim, M.D.
  • Chief Medical Officer
  • --
  • Julie Burgess
  • Chief Accounting Officer
  • --
  • Dr. Simeon J. George, M.B.A.,M.D.
  • Lead Independent Director
  • 95.70K
  • John P. Schmid
  • Independent Director
  • 106.70K
  • Dr. Stella Xu, PhD
  • Independent Director
  • 94.20K
  • Dr. Heather Berger, PhD
  • Independent Director
  • 94.20K
  • Dr. Arsani William, M.D.
  • Independent Director
  • 104.20K
  • Deepa Prasad
  • Independent Director
  • 94.20K
  • Dr. Rodney W. Lappe, PhD
  • Independent Director
  • 228.56K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg